These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36136327)

  • 21. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 23. Investigation of a Tumor Location-Specific Therapeutic Strategy for Intrahepatic Cholangiocarcinoma.
    Kosaka H; Kaibori M; Matsui K; Ishizaki M; Matsushima H; Sekimoto M
    Asian Pac J Cancer Prev; 2021 May; 22(5):1485-1493. PubMed ID: 34048177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients.
    Yamashita Y; Taketomi A; Morita K; Fukuhara T; Ueda S; Sanefuji K; Iguchi T; Kayashima H; Sugimachi K; Maehara Y
    Anticancer Res; 2008; 28(4C):2353-9. PubMed ID: 18751418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of perioperative and oncologic outcomes between open and laparoscopic liver resection for intrahepatic cholangiocarcinoma.
    Lee W; Park JH; Kim JY; Kwag SJ; Park T; Jeong SH; Ju YT; Jung EJ; Lee YJ; Hong SC; Choi SK; Jeong CY
    Surg Endosc; 2016 Nov; 30(11):4835-4840. PubMed ID: 26902611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MEGNA Score and Preoperative Anemia are Major Prognostic Factors After Resection in the German Intrahepatic Cholangiocarcinoma Cohort.
    Schnitzbauer AA; Eberhard J; Bartsch F; Brunner SM; Ceyhan GO; Walter D; Fries H; Hannes S; Hecker A; Li J; Oldhafer K; Rahbari N; Rauchfuss F; Schlitt HJ; Settmacher U; Stavrou G; Weitz J; Lang H; Bechstein WO; Rückert F
    Ann Surg Oncol; 2020 Apr; 27(4):1147-1155. PubMed ID: 31646454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short- and long-term outcomes following robotic and open resection for intrahepatic cholangiocarcinoma: A national cohort study.
    Hamad A; Ansari A; Li Y; Shen C; Cloyd J; Pawlik TM; Ejaz A
    Surg Oncol; 2022 Aug; 43():101790. PubMed ID: 35717859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome after liver resection for primary and recurrent intrahepatic cholangiocarcinoma.
    Nickkholgh A; Ghamarnejad O; Khajeh E; Tinoush P; Bruckner T; Kulu Y; Mieth M; Goeppert B; Roessler S; Weiss KH; Hoffmann K; Büchler MW; Mehrabi A
    BJS Open; 2019 Dec; 3(6):793-801. PubMed ID: 31832586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Textbook oncologic outcome in pancreaticoduodenectomy: Do regionalization efforts make sense?
    Kulshrestha S; Sweigert PJ; Tonelli C; Bunn C; Luchette FA; Abdelsattar ZM; Pawlik TM; Baker MS
    J Surg Oncol; 2022 Mar; 125(3):414-424. PubMed ID: 34617590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors.
    Alaimo L; Moazzam Z; Lima HA; Endo Y; Ruzzenente A; Guglielmi A; Ratti F; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Popescu I; Poultsides GA; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Kitago M; Aucejo F; Sasaki K; Fields RC; Hugh T; Lam V; Pawlik TM
    Surgery; 2023 Dec; 174(6):1384-1392. PubMed ID: 37741777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.
    Miyazaki M; Ito H; Nakagawa K; Ambiru S; Shimizu H; Okaya T; Shinmura K; Nakajima N
    J Am Coll Surg; 1999 Dec; 189(6):575-83. PubMed ID: 10589594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: A multi-institutional analysis.
    Reames BN; Ejaz A; Koerkamp BG; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Martel G; Marsh JW; Pawlik TM
    J Surg Oncol; 2017 Aug; 116(2):133-139. PubMed ID: 28411373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of Cure of Intrahepatic Cholangiocarcinoma After Hepatic Resection.
    Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Okabe H; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Yoshizumi T; Maehara Y; Baba H
    Anticancer Res; 2017 Dec; 37(12):6971-6975. PubMed ID: 29187482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma.
    Zhu H; Wang L; Wang M; He X; Xu W; Zhu W; Zhao Y; Wang L
    Am J Surg; 2021 Aug; 222(2):383-389. PubMed ID: 33388133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of tumor location on the value of lymphadenectomy for intrahepatic cholangiocarcinoma.
    Endo Y; Moazzam Z; Lima HA; Alaimo L; Munir MM; Shaikh CF; Guglielmi A; Aldrighetti L; Weiss M; Bauer TW; Alexandrescu S; Poultsides GA; Kitago M; Maithel SK; Marques HP; Martel G; Pulitano C; Shen F; Cauchy F; Koerkamp BG; Endo I; Pawlik TM
    HPB (Oxford); 2023 Jun; 25(6):650-658. PubMed ID: 36894491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Routine lymph node dissection may be not suitable for all intrahepatic cholangiocarcinoma patients: results of a monocentric series.
    Li DY; Zhang HB; Yang N; Quan Y; Yang GS
    World J Gastroenterol; 2013 Dec; 19(47):9084-91. PubMed ID: 24379635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of lymphadenectomy in the surgical treatment of intrahepatic cholangiocarcinoma: A review.
    Sposito C; Droz Dit Busset M; Virdis M; Citterio D; Flores M; Bongini M; Niger M; Mazzaferro V
    Eur J Surg Oncol; 2022 Jan; 48(1):150-159. PubMed ID: 34412956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cholangiocellular cancer: the state of the problem and ways to improve the results of surgical treatment].
    Patyutko YI; Polyakov AN; Podluzhnyi DV; Syskova AY; Sagaidak IV; Kotel'nikov AG; Sergeeva ON; Pokataev IA
    Khirurgiia (Mosk); 2018; (12):30-37. PubMed ID: 30560842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.